Tạp chí Tim mạch học Việt Nam

Article detail

Article detail description

Home
NGHIÊN CỨU LÂM SÀNG Issue: Issue 99, 2022

Relationship between hypochromic anemia and mortality and re-hospitalization rates in patients with acute heart failure

Đặng Văn Phúc: Bộ môn Tim mạch, Đại học Y Hà Nội; Phạm Minh Tuấn: Bộ môn Tim mạch, Đại học Y Hà Nội;
Published: November 1, 2021
Views: 152

Abstract

Background: Hypochromic red blood cells are defined as Mean Corpuscular Hemoglobin Concentration (MCHC), which is a simple index to assess body iron deficiency, ≤ 320 g/L. Our study was aimed at evaluating the prognostic value of MCHC with mortality and re-hospitalization rates in patients with acute heart failure.
Methods and results: The study was conducted on 201 patients with acute heart failure. These patients will be divided into 2 groups: The group with MCHC decrease (MCHC ≤ 320 g/L) and the group without MCHC decrease (MCHC > 320 g/L) based on the value of MCHC index quantified within 24 hours after hospitalization. The patients were monitored for 6 months after being discharged from hospital. The Kaplan-Meier Curve showed that the mortality and re-hospitalization rates in the group with MCHC decrease were significantly higher than those in the group without MCHC decrease (log rank p <0.001). Multivariable Cox proportional hazards regression analysis illustrated that decreased MCHC (HR: 1,040 95% CI 1.022 – 1,059) was an independent prognostic factor of mortality and re-hospitalization within 6 months in patients with acute heart failure.
Conclution: MCHC is an independent prognostic factor of mortality and re-hospitalization in patients with acute heart failure.

References

1.
1. Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics-2019 Update: A report from the American Heart Association. Circulation. 2019; 139(10): e56-e528.
2.
2. Yancy Clyde W., Jessup Mariell, Bozkurt Biykem, et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure. J Am Coll Cardiol. 2013; 62(16): e147-e239.
3.
3. Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. CircHeartFail. 2013; 6(3):606-619.
4.
4. Phạm Lê Tuấn, Nguyễn Nam Liên, Phan Lê Thu Hằng. Niên giám thống kê Y tế 2015. NhàxuấtbảnYhọc Hà Nội. 2017:229.
5.
5. Phạm Mạnh Hùng. Lâm sàng tim mạch học. Nhà xuất bản Y học Hà Nội. 2019; 461-504.
6.
Kleber M, Kozhuharov N, Sabti Z, et al. Relative hypochromia and mortality in acute heart failure. IntJCardiol. 2019; 286:104-110.
7.
6. Silverberg DS, Wexler D, Schwartz D. Is Correction of Iron Deficiency a New Addition to the Treatment of the Heart Failure? Int J Mol Sci. 2015; 16(6):14056-14074.
8.
7. Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J. 2013; 34(11):816-829.
9.
8. Sultana GS, Haque SA, Sultana T, Ahmed AN. Value of red cell distribution width (RDW) and RBC indices in the detection of iron deficiency anemia. Mymensingh Med J MMJ. 2013; 22(2):370-376.

Files

Article Views152
Document Views1
Downloads0
Section NGHIÊN CỨU LÂM SÀNG